Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target

Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…

Read More

A Simple Act of Kindness Creates a Lasting Impact at Texas Children’s Hospital

Sometimes the most meaningful moments of care happen when someone simply takes the time to be present.  While making her regular rounds at Texas Children’s Hospital, The Woodlands, Environmental Services (EVS) Houskeeper Maruja Caballero, heard a young patient crying. When she arrived at his room to collect the trash, she stopped in her tracks and moved into action to help.  …

Read More

The Art of Political Jiu-Jitsu: Project 2025 and Donald Trump

By MIKE MAGEE Funny think about that Project 2025’s  “Mandate for Leadership.” Trump declared in this week’s  debate, “I know nothing about it.” But in addition to the vast majority of authors and editors of the document having served in the prior Trump administration, the former President’s name is mentioned in the 887 page document…

Read More

Bevey Miner, Consensus Cloud Solutions

This is a transcript of my HIMSS interview with Bevey Miner, EVP Healthcare Strategy & Policy at Consensus Cloud Solutions. Usually I’d show the video but in this case my fancy new microphone didn’t work so you’d only hear a one sided conversation. Luckily Youtube’s transcript somewhat came to the rescue–Matthew Holt Matthew: Another THCB…

Read More